NCT03865225

Brief Summary

This explorative prospective study aims to assess the effects of heart rate variability biofeedback (HRV biofeedback) in patients with acute ischaemic stroke. Furthermore, the investigators aim to examine the impact of the intervention on cardiac autonomic function and further autonomic parameters such as sudomotor (sympathetic perspiratory gland function) and vasomotor function (sympathetic arterial function). Patients testing is going to be conducted at the Department of Neurology, University Hospital Carl Gustave Carus, Dresden, Germany.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 25, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 3, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 6, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2019

Completed
Last Updated

January 12, 2021

Status Verified

January 1, 2021

Enrollment Period

8 months

First QC Date

March 3, 2019

Last Update Submit

January 9, 2021

Conditions

Keywords

Ischaemic StrokeHeart Rate VariabilityAutonomic Nervous Systemcardiac autonomic dysfunctionsudomotor functionvasomotor function

Outcome Measures

Primary Outcomes (3)

  • Heart rate variability in acute ischaemic stroke patients

    Measurement of heart rate variability in acute ischaemic stroke patients

    Change from Baseline Heart rate variability at 3 days

  • Severity of autonomic symptoms

    Assessment of autonomic symptoms with Survey of Autonomic Symptoms

    Change from Baseline Severity of autonomic symptoms at 3 days and at 3 months

  • Measurement of sudomotor and vasomotor function

    Assessment of sudomotor and vasomotor function in patients with acute ischaemic stroke prior and after intervention

    Change from Baseline Measurement of sudomotor and vasomotor function at 3 days

Secondary Outcomes (2)

  • Severity of neurological stroke symptoms

    Change from Baseline Severity of neurological stroke symptoms at 3 days

  • Degree of disability in patients with acute ischemic stroke

    Change from Baseline Functional Outcome at 3 days and at 3 months

Study Arms (2)

Control group acute ischaemic stroke

SHAM COMPARATOR

Acute ischaemic stroke patients receiving 9 x 10 minutes sham-biofeedback over a period of three days

Other: Sham-Biofeedback

Treatment group acute ischaemic stroke

ACTIVE COMPARATOR

Acute ischaemic stroke patients receiving 9 x 10 minutes biofeedback sessions over period of three days

Other: Biofeedback

Interventions

9 x 10 minutes biofeedback sessions over period of three days

Treatment group acute ischaemic stroke

9 x 10 minutes sham-biofeedback sessions over period of three days

Control group acute ischaemic stroke

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • male and female subjects aged between 18 and 90
  • written and oral informed consent
  • evidence of an ischaemic lesion on cranial computed tomography scan or magnetic resonance imaging

You may not qualify if:

  • intake of any tricyclic antidepressant within the last 14 days
  • atrial fibrillation
  • prior diagnosed autonomic neuropathy
  • malignant cerebral infarct or indication for treatment at intensive care unit
  • aphasia or cognitive deficit with resulted inability to participate in Heart rate variability-biofeedback training
  • respiratory insufficiency
  • blindness, deafness or other physical limitations with resulted inability to participate in heart rate variability-biofeedback training

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Neurology, University Hospital Carl Gustav Carus Dresden, Germany

Dresden, Saxony, 01307, Germany

Location

Related Publications (2)

  • Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25. No abstract available. Erratum In: Circulation. 2017 Mar 7;135(10):e646. doi: 10.1161/CIR.0000000000000491. Circulation. 2017 Sep 5;136(10):e196. doi: 10.1161/CIR.0000000000000530.

    PMID: 28122885BACKGROUND
  • Siepmann T, Ohle P, Sedghi A, Simon E, Arndt M, Pallesen LP, Ritschel G, Barlinn J, Reichmann H, Puetz V, Barlinn K. Randomized Sham-Controlled Pilot Study of Neurocardiac Function in Patients With Acute Ischaemic Stroke Undergoing Heart Rate Variability Biofeedback. Front Neurol. 2021 May 26;12:669843. doi: 10.3389/fneur.2021.669843. eCollection 2021.

MeSH Terms

Conditions

Primary DysautonomiasIschemic Stroke

Interventions

Biofeedback, Psychology

Condition Hierarchy (Ancestors)

Autonomic Nervous System DiseasesNervous System DiseasesStrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesFeedback, Psychological

Study Officials

  • Timo Siepmann, PD, MD

    University Hospital Carl Gustav Carus Dresden, Germany

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Sham biofeedback intervention
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Doctor of Medicine, Principal Investigator, Head of neurological emergency room, University Hospital Carl Gustav Carus

Study Record Dates

First Submitted

March 3, 2019

First Posted

March 6, 2019

Study Start

November 25, 2018

Primary Completion

August 1, 2019

Study Completion

November 1, 2019

Last Updated

January 12, 2021

Record last verified: 2021-01

Locations